The proposed rule, if finalized in its current form, would be an important step forward for patient safety.
On the recordMarch 31, 2014
Source
congress.govEditor's note · Context
Waxman supports a proposed FDA rule to enhance safety information for generic drugs.
Share
More from Henry Waxman
Dec 2, 2014
Our legislation improves the early warning reporting system by making more reported information public and ensuring that NHTSA receives significantly more information for manufacturers on any fatal incident involving a safety defect.
Nov 19, 2014
So what we are seeing is something that sounds good from a party that has no credibility to say that they are for more science information. What they would do is limit what EPA would be able to use to determine, based on the science, what…
Jul 11, 2019
It is not for the President to say or to obstruct congressional deliberations and investigations or other legitimate functions.





